BioNTech SE (BNTX) Shares Repurchased (2022 - 2023)
BioNTech SE (BNTX) posted Shares Repurchased of -$860751.9 for Q4 2023, up 99.74% on a QoQ basis from -$328.4 million in Q3 2023.
BioNTech SE (BNTX) has 2 years of Shares Repurchased data on file, last reported at -$860751.9 in Q4 2023.
- In Q4 2023, Shares Repurchased changed N/A year-over-year to -$860751.9; the TTM figure through Dec 2023 stood at -$799.7 million (changed N/A YoY), while the FY2023 annual figure was -$794.6 million, changed N/A from the prior year.
- Shares Repurchased advanced to -$860751.9 in Q4 2023, from -$328.4 million in the prior quarter.
- Across five years, Shares Repurchased topped out at -$860751.9 in Q4 2023 and bottomed at -$649.1 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 336.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 794.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -860,751.93 |
| Dec 31, 2023 | -860,751.93 |
| Sep 30, 2023 | -328.43 Mn |
| Sep 30, 2023 | -328.43 Mn |
| Jun 30, 2023 | -167.69 Mn |
| Jun 30, 2023 | -167.69 Mn |
| Mar 31, 2023 | -302.68 Mn |
| Mar 31, 2023 | -302.68 Mn |
| Sep 30, 2022 | -649.13 Mn |
| Sep 30, 2022 | -649.13 Mn |
| Jun 30, 2022 | -306.14 Mn |
| Jun 30, 2022 | -306.14 Mn |